Shopping Cart
- Remove All
- Your shopping cart is currently empty
Epalrestat (ONO2235), an aldose reductase inhibitor, is well tolerated in Long-term therapy. It can effectually ameliorate the associated symptoms of diabetic neuropathy and delay the progression of the disease, particularly in patients with limited microangiopathy and good glycemic control.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | $30 | In Stock | |
25 mg | $44 | In Stock | |
50 mg | $61 | In Stock | |
100 mg | $87 | In Stock | |
200 mg | $127 | In Stock | |
500 mg | $209 | In Stock | |
1 mL x 10 mM (in DMSO) | $48 | In Stock |
Description | Epalrestat (ONO2235), an aldose reductase inhibitor, is well tolerated in Long-term therapy. It can effectually ameliorate the associated symptoms of diabetic neuropathy and delay the progression of the disease, particularly in patients with limited microangiopathy and good glycemic control. |
Alias | ONO2235 |
Molecular Weight | 319.4 |
Formula | C15H13NO3S2 |
Cas No. | 82159-09-9 |
Smiles | CC(=C/C1=CC=CC=C1)\C=C1/SC(=S)N(CC(O)=O)C1=O |
Relative Density. | 1.43 g/cm3 |
Storage | keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 9 mg/mL (28.18 mM) | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.